Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Zilovertamab Vedotin (ZV) Alone or in Combination With Nemtabrutinib in Relapsed or Refractory (R/R) Aggressive and Indolent B-Cell Malignancies (waveLINE-006): An Open-Label, Phase 2 Basket Study
- Authors
- Paskiewicz-Kozik, Ewa; Glimelius, Ingrid; Moreira, Claudia; Garrido, Marcelo; Ernst, Daniel; Jurczak, Wojciech; Merryman, Reid; Kim, Won Seog; Ozcan, Muhit; Santoro, Armando; Sawalha, Yazeed; Berkovits, Alejandro; Ren, Yixin; Ogbu, Uzor; Yusuf, Rushdia; Zinzani, Pier Luigi
- Issue Date
- Sep-2024
- Publisher
- CIG MEDIA GROUP, LP
- Keywords
- ABCL; B-cell lymphoma; antibody-drug conjugate; ROR1; Bruton's tyrosine kinase inhibitor; Phase 2
- Citation
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.24, pp S483 - S484
- Indexed
- SCIE
SCOPUS
- Journal Title
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Volume
- 24
- Start Page
- S483
- End Page
- S484
- ISSN
- 2152-2650
2152-2669
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.